{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:24:12Z","timestamp":1789147452644,"version":"build-2803163510"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2024YFE0201300"],"award-info":[{"award-number":["2024YFE0201300"]}]},{"name":"National Key Research and Development Program of China","award":["2024YFE0201300"],"award-info":[{"award-number":["2024YFE0201300"]}]},{"name":"National Key Research and Development Program of China","award":["2024YFE0201300"],"award-info":[{"award-number":["2024YFE0201300"]}]},{"name":"National Key Research and Development Program of China","award":["2024YFE0201300"],"award-info":[{"award-number":["2024YFE0201300"]}]},{"name":"National Key Research and Development Program of China","award":["2024YFE0201300"],"award-info":[{"award-number":["2024YFE0201300"]}]},{"name":"National Key Research and Development Program of China","award":["2024YFE0201300"],"award-info":[{"award-number":["2024YFE0201300"]}]},{"name":"National Key Research and Development Program of China","award":["2024YFE0201300"],"award-info":[{"award-number":["2024YFE0201300"]}]},{"name":"National Key Research and Development Program of China","award":["2024YFE0201300"],"award-info":[{"award-number":["2024YFE0201300"]}]},{"name":"National Key Research and Development Program of China","award":["2024YFE0201300"],"award-info":[{"award-number":["2024YFE0201300"]}]},{"name":"Science and Technology Development Fund, Macau SAR","award":["File no. 0161\/2024\/AMJ"],"award-info":[{"award-number":["File no. 0161\/2024\/AMJ"]}]},{"name":"State Key Laboratory Special Fund","award":["2060204"],"award-info":[{"award-number":["2060204"]}]},{"name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","award":["2023-I2M-2-001"],"award-info":[{"award-number":["2023-I2M-2-001"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82173875"],"award-info":[{"award-number":["82173875"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"DOI":"10.1186\/s12931-025-03435-y","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T05:45:13Z","timestamp":1765518313000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["S1PR3 Inhibition in alveolar epithelial cells alleviates pulmonary fibrosis by enhancing alveolar barrier function"],"prefix":"10.1186","volume":"27","author":[{"given":"Mengyao","family":"Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guodong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enjia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MingJin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoguang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxi","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"issue":"8","key":"3435_CR1","doi-asserted-by":"publisher","first-page":"L731","DOI":"10.1152\/ajplung.00309.2014","volume":"308","author":"K Brune","year":"2015","unstructured":"Brune K, Frank J, Schwingshackl A, Finigan J, Sidhaye VK. Pulmonary epithelial barrier function: some new players and mechanisms. Am J Physiol Lung Cell Mol Physiol. 2015;308(8):L731-45.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"3","key":"3435_CR2","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1152\/physrev.00022.2004","volume":"85","author":"JN Maina","year":"2005","unstructured":"Maina JN, West JB. Thin and strong! The bioengineering dilemma in the structural and functional design of the blood-gas barrier. Physiol Rev. 2005;85(3):811\u201344.","journal-title":"Physiol Rev"},{"key":"3435_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/978-1-4614-7351-0_4","volume":"13","author":"V Kim","year":"2013","unstructured":"Kim V, Kato K, Kim KC, Lillehoj EP. Role of epithelial cells in chronic inflammatory lung disease. Smok Lung Inflamm. 2013;13:81\u201398.","journal-title":"Smok Lung Inflamm"},{"issue":"1","key":"3435_CR4","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1186\/s13054-024-05149-x","volume":"28","author":"W Fan","year":"2024","unstructured":"Fan W, Gui B, Zhou X, Li L, Chen H. A narrative review on lung injury: mechanisms, biomarkers, and monitoring. Crit Care. 2024;28(1):352.","journal-title":"Crit Care"},{"key":"3435_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1146\/annurev-pathol-011110-130158","volume":"6","author":"MA Matthay","year":"2011","unstructured":"Matthay MA, Zemans RL. The acute respiratory distress syndrome: pathogenesis and treatment. Annu Rev Pathol. 2011;6:147\u201363.","journal-title":"Annu Rev Pathol"},{"key":"3435_CR6","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1146\/annurev.pathol.4.110807.092145","volume":"4","author":"JC Hogg","year":"2009","unstructured":"Hogg JC, Timens W. The pathology of chronic obstructive pulmonary disease. Annu Rev Pathol. 2009;4:435\u201359.","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"3435_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/rr175","volume":"3","author":"M Selman","year":"2001","unstructured":"Selman M, Pardo A. Idiopathic pulmonary fibrosis: an epithelial\/fibroblastic cross-talk disorder. Respir Res. 2001;3(1):3.","journal-title":"Respir Res"},{"issue":"1","key":"3435_CR8","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1186\/s12964-024-01925-y","volume":"22","author":"R Niayesh-Mehr","year":"2024","unstructured":"Niayesh-Mehr R, Kalantar M, Bontempi G, Montaldo C, Ebrahimi S, Allameh A, et al. The role of epithelial-mesenchymal transition in pulmonary fibrosis: lessons from idiopathic pulmonary fibrosis and COVID-19. Cell Commun Signal. 2024;22(1):542.","journal-title":"Cell Commun Signal"},{"key":"3435_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23116064","author":"WI Effendi","year":"2022","unstructured":"Effendi WI, Nagano T. Connective tissue growth factor in idiopathic pulmonary fibrosis: breaking the bridge. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23116064.","journal-title":"Int J Mol Sci"},{"key":"3435_CR10","doi-asserted-by":"crossref","unstructured":"Rosen H, Stevens RC, Hanson M, Roberts E, Oldstone MBA. Sphingosine-1-Phosphate and Its Receptors: Structure, Signaling, and Influence. Annual Review of Biochemistry. 2013;82(82):637\u2009\u2013\u200962.","DOI":"10.1146\/annurev-biochem-062411-130916"},{"issue":"3","key":"3435_CR11","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.apsb.2022.10.006","volume":"13","author":"M Hao","year":"2023","unstructured":"Hao M, Fu R, Tai J, Tian Z, Yuan X, Chen Y, et al. S1PR1 serves as a viable drug target against pulmonary fibrosis by increasing the integrity of the endothelial barrier of the lung. Acta Pharm Sin B. 2023;13(3):1110\u201327.","journal-title":"Acta Pharm Sin B"},{"issue":"4","key":"3435_CR12","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1165\/rcmb.2009-0223OC","volume":"43","author":"S Sammani","year":"2010","unstructured":"Sammani S, Moreno-Vinasco L, Mirzapoiazova T, Singleton PA, Chiang ET, Evenoski CL, et al. Differential effects of sphingosine 1-phosphate receptors on airway and vascular barrier function in the murine lung. Am J Respir Cell Mol Biol. 2010;43(4):394\u2013402.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"3435_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05220-9","volume":"22","author":"J Peng","year":"2024","unstructured":"Peng J, Tang R, He J, Yu Q, Wang D, Qi D. S1PR3 inhibition protects against LPS-induced ARDS by inhibiting NF-\u03baB and improving mitochondrial oxidative phosphorylation. J Transl Med. 2024;22(1):535.","journal-title":"J Transl Med"},{"key":"3435_CR14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.cca.2021.03.025","volume":"519","author":"Q Li","year":"2021","unstructured":"Li Q, Li Y, Lei C, Tan Y, Yi G. Sphingosine-1-phosphate receptor 3 signaling. Clin Chim Acta. 2021;519:32\u20139.","journal-title":"Clin Chim Acta"},{"issue":"7187","key":"3435_CR15","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/nature06663","volume":"452","author":"F Niessen","year":"2008","unstructured":"Niessen F, Schaffner F, Furlan-Freguia C, Pawlinski R, Bhattacharjee G, Chun J, et al. Dendritic cell PAR1-S1P3 signalling couples coagulation and inflammation. Nature. 2008;452(7187):654\u20138.","journal-title":"Nature"},{"issue":"1","key":"3435_CR16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12974-017-0882-x","volume":"14","author":"SS Dusaban","year":"2017","unstructured":"Dusaban SS, Chun J, Rosen H, Purcell NH, Brown JH. Sphingosine 1-phosphate receptor 3 and RhoA signaling mediate inflammatory gene expression in astrocytes. J Neuroinflammation. 2017;14(1):111.","journal-title":"J Neuroinflammation"},{"issue":"6","key":"3435_CR17","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1091\/mbc.e09-09-0812","volume":"21","author":"F Cencetti","year":"2010","unstructured":"Cencetti F, Bernacchioni C, Nincheri P, Donati C, Bruni P. Transforming growth factor-beta1 induces transdifferentiation of myoblasts into myofibroblasts via up-regulation of sphingosine kinase-1\/S1P3 axis. Mol Biol Cell. 2010;21(6):1111\u201324.","journal-title":"Mol Biol Cell"},{"issue":"3","key":"3435_CR18","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/cvr\/cvp312","volume":"85","author":"N Takuwa","year":"2010","unstructured":"Takuwa N, Ohkura S, Takashima S, Ohtani K, Okamoto Y, Tanaka T, et al. S1P3-mediated cardiac fibrosis in sphingosine kinase 1 transgenic mice involves reactive oxygen species. Cardiovasc Res. 2010;85(3):484\u201393.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"3435_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-017-0882-x","volume":"14","author":"SS Dusaban","year":"2017","unstructured":"Dusaban SS, Chun J, Rosen H, Purcell NH, Brown JH. Sphingosine 1-phosphate receptor 3 and RhoA signaling mediate inflammatory gene expression in astrocytes. J Neuroinflammation. 2017;14(1):111.","journal-title":"J Neuroinflammation"},{"issue":"9","key":"3435_CR20","doi-asserted-by":"publisher","first-page":"e106792","DOI":"10.1371\/journal.pone.0106792","volume":"9","author":"K Murakami","year":"2014","unstructured":"Murakami K, Kohno M, Kadoya M, Nagahara H, Fujii W, Seno T, et al. Knock out of S1P3 receptor signaling attenuates inflammation and fibrosis in bleomycin-induced lung injury mice model. PLoS One. 2014;9(9):e106792.","journal-title":"PLoS One"},{"issue":"4","key":"3435_CR21","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1136\/jcp.41.4.467","volume":"41","author":"T Ashcroft","year":"1988","unstructured":"Ashcroft T, Simpson JM, Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol. 1988;41(4):467\u201370.","journal-title":"J Clin Pathol"},{"issue":"3","key":"3435_CR22","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1002\/path.4530","volume":"236","author":"Y Luo","year":"2015","unstructured":"Luo Y, Xu W, Chen H, Warburton D, Dong R, Qian B, et al. A novel profibrotic mechanism mediated by TGF\u03b2-stimulated collagen prolyl hydroxylase expression in fibrotic lung mesenchymal cells. J Pathol. 2015;236(3):384\u201394.","journal-title":"J Pathol"},{"issue":"1","key":"3435_CR23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1172\/JCI93557","volume":"128","author":"J Herrera","year":"2018","unstructured":"Herrera J, Henke CA, Bitterman PB. Extracellular matrix as a driver of progressive fibrosis. J Clin Invest. 2018;128(1):45\u201353.","journal-title":"J Clin Invest"},{"key":"3435_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102509","volume":"57","author":"Z Pei","year":"2022","unstructured":"Pei Z, Qin Y, Fu X, Yang F, Huo F, Liang X, et al. Inhibition of ferroptosis and iron accumulation alleviates pulmonary fibrosis in a bleomycin model. Redox Biol. 2022;57:102509.","journal-title":"Redox Biol"},{"key":"3435_CR25","doi-asserted-by":"publisher","DOI":"10.1172\/JCI172058","author":"J May","year":"2023","unstructured":"May J, Mitchell JA, Jenkins RG. Beyond epithelial damage: vascular and endothelial contributions to idiopathic pulmonary fibrosis. J Clin Invest. 2023. https:\/\/doi.org\/10.1172\/JCI172058.","journal-title":"J Clin Invest"},{"key":"3435_CR26","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1146\/annurev-pathol-042320-030240","volume":"17","author":"BJ Moss","year":"2022","unstructured":"Moss BJ, Ryter SW, Rosas IO. Pathogenic mechanisms underlying idiopathic pulmonary fibrosis. Annu Rev Pathol. 2022;17:515\u201346.","journal-title":"Annu Rev Pathol"},{"key":"3435_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/proteomes6020017","author":"JY Lee","year":"2018","unstructured":"Lee JY, Wasinger VC, Yau YY, Chuang E, Yajnik V, Leong RW. Molecular pathophysiology of epithelial barrier dysfunction in inflammatory bowel diseases. Proteomes. 2018. https:\/\/doi.org\/10.3390\/proteomes6020017.","journal-title":"Proteomes"},{"issue":"1","key":"3435_CR28","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/628157","volume":"2015","author":"A Michielan","year":"2015","unstructured":"Michielan A, D\u2019Inc\u00e0 R. Intestinal permeability in inflammatory bowel disease: pathogenesis, clinical evaluation, and therapy of leaky gut. Mediators Inflamm. 2015;2015(1):628157.","journal-title":"Mediators Inflamm"},{"issue":"5","key":"3435_CR29","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.3748\/wjg.v20.i5.1165","volume":"20","author":"L Antoni","year":"2014","unstructured":"Antoni L, Nuding S, Wehkamp J, Stange EF. Intestinal barrier in inflammatory bowel disease. World J Gastroenterol. 2014;20(5):1165\u201379.","journal-title":"World J Gastroenterol"},{"issue":"7","key":"3435_CR30","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1053\/j.gastro.2007.02.052","volume":"132","author":"BT Schwarz","year":"2007","unstructured":"Schwarz BT, Wang F, Shen L, Clayburgh DR, Su L, Wang Y, et al. Light signals directly to intestinal epithelia to cause barrier dysfunction via cytoskeletal and endocytic mechanisms. Gastroenterology. 2007;132(7):2383\u201394.","journal-title":"Gastroenterology"},{"issue":"5","key":"3435_CR31","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1378\/chest.09-0510","volume":"136","author":"RM Strieter","year":"2009","unstructured":"Strieter RM, Mehrad B. New mechanisms of pulmonary fibrosis. Chest. 2009;136(5):1364\u201370.","journal-title":"Chest"},{"key":"3435_CR32","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev.med.55.091902.103810","volume":"55","author":"VJ Thannickal","year":"2004","unstructured":"Thannickal VJ, Toews GB, White ES, Lynch JP, Martinez FJ. Mechanisms of pulmonary fibrosis. Annu Rev Med. 2004;55:395\u2013417.","journal-title":"Annu Rev Med"},{"issue":"4","key":"3435_CR33","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1513\/pats.200601-003TK","volume":"3","author":"M Selman","year":"2006","unstructured":"Selman M, Pardo A. Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers. Proc Am Thorac Soc. 2006;3(4):364\u201372.","journal-title":"Proc Am Thorac Soc"},{"issue":"1","key":"3435_CR34","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1164\/ajrccm.164.1.2007077","volume":"164","author":"N Mogulkoc","year":"2001","unstructured":"Mogulkoc N, Brutsche MH, Bishop PW, Greaves SM, Horrocks AW, Egan JJ. Pulmonary function in idiopathic pulmonary fibrosis and referral for lung transplantation. Am J Respir Crit Care Med. 2001;164(1):103\u20138.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"3435_CR35","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.humpath.2012.08.016","volume":"44","author":"E Lappi-Blanco","year":"2013","unstructured":"Lappi-Blanco E, Lehtonen ST, Sormunen R, Merikallio HM, Soini Y, Kaarteenaho RL. Divergence of tight and adherens junction factors in alveolar epithelium in pulmonary fibrosis. Hum Pathol. 2013;44(5):895\u2013907.","journal-title":"Hum Pathol"},{"issue":"34","key":"3435_CR36","doi-asserted-by":"publisher","first-page":"13785","DOI":"10.1073\/pnas.1221309110","volume":"110","author":"AO Awojoodu","year":"2013","unstructured":"Awojoodu AO, Ogle ME, Sefcik LS, Bowers DT, Martin K, Brayman KL, et al. Sphingosine 1-phosphate receptor 3 regulates recruitment of anti-inflammatory monocytes to microvessels during implant arteriogenesis. Proc Natl Acad Sci U S A. 2013;110(34):13785\u201390.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"3435_CR37","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1161\/CIRCRESAHA.107.170779","volume":"102","author":"JE Hughes","year":"2008","unstructured":"Hughes JE, Srinivasan S, Lynch KR, Proia RL, Ferdek P, Hedrick CC. Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages. Circ Res. 2008;102(8):950\u20138.","journal-title":"Circ Res"},{"issue":"14","key":"3435_CR38","doi-asserted-by":"publisher","first-page":"13839","DOI":"10.1074\/jbc.M311743200","volume":"279","author":"MG Sanna","year":"2004","unstructured":"Sanna MG, Liao J, Jo E, Alfonso C, Ahn MY, Peterson MS, et al. Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate. J Biol Chem. 2004;279(14):13839\u201348.","journal-title":"J Biol Chem"},{"key":"3435_CR39","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/978-3-7091-1511-4_10","volume":"216","author":"T Abbasi","year":"2013","unstructured":"Abbasi T, Garcia JG. Sphingolipids in lung endothelial biology and regulation of vascular integrity. Handb Exp Pharmacol. 2013;216:201\u201326.","journal-title":"Handb Exp Pharmacol"},{"issue":"12","key":"3435_CR40","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1016\/j.bbamem.2006.06.015","volume":"1758","author":"C Donati","year":"2006","unstructured":"Donati C, Bruni P. Sphingosine 1-phosphate regulates cytoskeleton dynamics: implications in its biological response. Biochim Biophys Acta. 2006;1758(12):2037\u201348.","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"3435_CR41","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1002\/cm.20486","volume":"67","author":"PR Gil","year":"2010","unstructured":"Gil PR, Japtok L, Kleuser B. Sphingosine 1-phosphate mediates chemotaxis of human primary fibroblasts via the S1P-receptor subtypes S1P\u2081 and S1P\u2083 and Smad-signalling. Cytoskeleton (Hoboken). 2010;67(12):773\u201383.","journal-title":"Cytoskeleton (Hoboken)"},{"issue":"Pt 13","key":"3435_CR42","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1242\/jcs.076794","volume":"124","author":"ES Kim","year":"2011","unstructured":"Kim ES, Kim JS, Kim SG, Hwang S, Lee CH, Moon A. Sphingosine 1-phosphate regulates matrix metalloproteinase-9 expression and breast cell invasion through S1P3-G\u03b1q coupling. J Cell Sci. 2011;124(Pt 13):2220\u201330.","journal-title":"J Cell Sci"},{"key":"3435_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2020.109861","volume":"78","author":"C Donati","year":"2021","unstructured":"Donati C, Cencetti F, Bernacchioni C, Vannuzzi V, Bruni P. Role of sphingosine 1-phosphate signalling in tissue fibrosis. Cell Signal. 2021;78:109861.","journal-title":"Cell Signal"},{"issue":"4","key":"3435_CR44","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.2353\/ajpath.2009.090037","volume":"175","author":"C Li","year":"2009","unstructured":"Li C, Jiang X, Yang L, Liu X, Yue S, Li L. Involvement of sphingosine 1-phosphate (SIP)\/S1P3 signaling in cholestasis-induced liver fibrosis. Am J Pathol. 2009;175(4):1464\u201372.","journal-title":"Am J Pathol"},{"issue":"3","key":"3435_CR45","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1002\/jcp.29138","volume":"235","author":"L Gong","year":"2020","unstructured":"Gong L, Wu X, Li X, Ni X, Gu W, Wang X, et al. S1PR3 deficiency alleviates radiation-induced pulmonary fibrosis through the regulation of epithelial-mesenchymal transition by targeting miR-495-3p. J Cell Physiol. 2020;235(3):2310\u201324.","journal-title":"J Cell Physiol"},{"issue":"1","key":"3435_CR46","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1186\/s12967-024-05220-9","volume":"22","author":"J Peng","year":"2024","unstructured":"Peng J, Tang R, He J, Yu Q, Wang D, Qi D. S1PR3 inhibition protects against LPS-induced ARDS by inhibiting NF-\u03baB and improving mitochondrial oxidative phosphorylation. J Transl Med. 2024;22(1):535.","journal-title":"J Transl Med"},{"issue":"9","key":"3435_CR47","doi-asserted-by":"publisher","first-page":"963","DOI":"10.2174\/15680096113136660102","volume":"13","author":"Y Wang","year":"2013","unstructured":"Wang Y, Shi J, Chai K, Ying X, Zhou BP. The role of snail in EMT and tumorigenesis. Curr Cancer Drug Targets. 2013;13(9):963\u201372.","journal-title":"Curr Cancer Drug Targets"},{"issue":"11","key":"3435_CR48","doi-asserted-by":"publisher","first-page":"4875","DOI":"10.1091\/mbc.e08-05-0506","volume":"19","author":"D Medici","year":"2008","unstructured":"Medici D, Hay ED, Olsen BR. Snail and slug promote epithelial-mesenchymal transition through beta-catenin-T-cell factor-4-dependent expression of transforming growth factor-beta3. Mol Biol Cell. 2008;19(11):4875\u201387.","journal-title":"Mol Biol Cell"},{"issue":"1","key":"3435_CR49","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12943-016-0502-x","volume":"15","author":"SJ Serrano-Gomez","year":"2016","unstructured":"Serrano-Gomez SJ, Maziveyi M, Alahari SK. Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications. Mol Cancer. 2016;15(1):18.","journal-title":"Mol Cancer"},{"issue":"4","key":"3435_CR50","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1124\/mol.109.061481","volume":"77","author":"A Murakami","year":"2010","unstructured":"Murakami A, Takasugi H, Ohnuma S, Koide Y, Sakurai A, Takeda S, et al. Sphingosine 1-phosphate (S1P) regulates vascular contraction via S1P3 receptor: investigation based on a new S1P3 receptor antagonist. Mol Pharmacol. 2010;77(4):704\u201313.","journal-title":"Mol Pharmacol"},{"issue":"3","key":"3435_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2024.101244","volume":"12","author":"H Qiu","year":"2025","unstructured":"Qiu H, Liu J, You J, Zhou O, Hao C, Shu Y, et al. Inhibition of sphingosine 1-phosphate receptor 3 ameliorates bleomycin-induced pulmonary fibrosis by suppressing macrophage M2 polarization. Genes & Diseases. 2025;12(3):101244.","journal-title":"Genes & Diseases"},{"key":"3435_CR52","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/978-1-4939-7113-8_2","volume":"1627","author":"T Liu","year":"2017","unstructured":"Liu T, De Los Santos FG, Phan SH. The bleomycin model of pulmonary fibrosis. Methods Mol Biol. 2017;1627:27\u201342.","journal-title":"Methods Mol Biol"},{"issue":"2","key":"3435_CR53","doi-asserted-by":"publisher","first-page":"L152","DOI":"10.1152\/ajplung.00313.2007","volume":"294","author":"BB Moore","year":"2008","unstructured":"Moore BB, Hogaboam CM. Murine models of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2008;294(2):L152\u201360.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"3435_CR54","doi-asserted-by":"publisher","first-page":"10245","DOI":"10.1038\/s41598-022-14618-8","volume":"12","author":"ST Tsikis","year":"2022","unstructured":"Tsikis ST, Fligor SC, Hirsch TI, Pan A, Yu LJ, Kishikawa H, et al. Lipopolysaccharide-induced murine lung injury results in long-term pulmonary changes and downregulation of angiogenic pathways. Sci Rep. 2022;12(1):10245.","journal-title":"Sci Rep"},{"issue":"4","key":"3435_CR55","doi-asserted-by":"publisher","first-page":"373","DOI":"10.4062\/biomolther.2018.215","volume":"27","author":"JY Heo","year":"2019","unstructured":"Heo JY, Im DS. Pro-inflammatory role of S1P(3) in macrophages. Biomol Ther (Seoul). 2019;27(4):373\u201380.","journal-title":"Biomol Ther (Seoul)"},{"key":"3435_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113341","volume":"153","author":"H Chen","year":"2022","unstructured":"Chen H, Wang J, Zhang C, Ding P, Tian S, Chen J, et al. Sphingosine 1-phosphate receptor, a new therapeutic direction in different diseases. Biomed Pharmacother. 2022;153:113341.","journal-title":"Biomed Pharmacother"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03435-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-025-03435-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03435-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T16:02:59Z","timestamp":1768406579000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12931-025-03435-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3435"],"URL":"https:\/\/doi.org\/10.1186\/s12931-025-03435-y","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"28 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was approved by the Institutional Ethics Committee of Institute of Materia Medica, under approval number 00006013.All participants provided written informed consent before inclusion in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have reviewed the final version of the manuscript and consent to its submission and potential publication in\n                      Respiratory Research\n                      .For studies involving individual participants, written consent for publication of any potentially identifiable data or images was obtained from the participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15"}}